Lori Muffly, MD¹, Snegha Ananth, MBBS², Lindsay Danley^3*, Caroline Wagner^3*, Diana Kordek^3*, Kimi DeNoble^4*, Ayesha Fraser^3*, Emily Egeler^5*, Alfonso Molina, MD, MPH⁶, Zachary Ehlinger, MS^5*, Moksha Desai, MS^5*, Hossein Daghagh^3*, Ramya Tunuguntla, PhD^7*, Annie K. Brown, MS^8*, Raquel Ibañez^9*, Anne Marijn Kramer, MD, PhD¹⁰, Zinaida Good, PhD⁵, Sally Arai, MD¹¹, Laura Johnston, MD¹¹, Robert Lowsky, MD^1*, Andrew R. Rezvani^11*, Judith Shizuru^11*, Lekha Mikkilineni, MD, MA¹², Parveen Shiraz^11*, Surbhi Sidana, MD¹, Wen-Kai Weng, MD, PhD¹², Vanessa E. Kennedy, MD¹², Sushma Bharadwaj, MD¹², Saurabh Dahiya, MD¹³, Matthew J. Frank, MD, PhD¹², Everett H. Meyer, MD, PhD¹, Robert S. Negrin, MD¹¹, Steven A. Feldman, PhD^14*, Crystal L. Mackall, MD⁵, Bita Sahaf^11*, David B. Miklos, MD, PhD¹⁵ and Melody Smith, MD, MS¹

¹Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
²Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
³Stanford University, Division of Blood and Marrow Transplant and Cellular Therapy, Stanford, CA
⁴Department of Bone Marrow Transplant and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
⁵Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
⁶Department of Medicine, Division of Hematology, Stanford University School of Medicine, San Carlos, CA
⁷Center for Cancer Cell Therapy, Stanford University, Stanford, CA
⁸Stanford University, Division of Blood and Marrow Transplant and Cellular Therapy, Stanford
⁹Stanford University School of Medicine, Stanford, CA
¹⁰Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Menlo Park, CA
¹¹Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
¹²Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
¹³Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Mountain View, CA
¹⁴Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA
¹⁵Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Palo Alto, CA

Brynn B. Duncan, MD^1*, Sara K. Silbert, MD², Alexander W. Rankin, MD^2*, Bonnie Yates, NP^2*, Lauren Little^2*, Toni Foley^2*, Hao-Wei Wang, MD, PhD^3*, Constance M. Yuan, MD, PhD^3*, Dana I. Delgado Colon, MD^3*, Yanyu Wang^4*, Jon Inglefield, PhD^4*, John A Ligon, MD^2,5*, Hannah W. Song, PhD^6*, Steven L. Highfill, PhD^6*, Haneen Shalabi, DO^2,7, David F. Stroncek, MD, MS⁸, Naomi Taylor, MD² and Nirali N. Shah, MD⁹

¹Pediatric Oncology Branch, NCI, Bethesda, MD
²Pediatric Oncology Branch, National Institutes of Health, Bethesda, MD
³Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Frederick National Laboratory for Cancer Research, Frederick, MD
⁵University of Florida, Gainesville, FL
⁶Center for Cellular Engineering, National Institutes of Health, Bethesda, MD
⁷Novartis Pharmaceuticals, East Hanover, NJ
⁸Center for Cellular Engineering, National Institutes of Health Clinical Center, Bethesda, MD
⁹Pediatric Oncology Branch, NIH, Bethesda, MD

Xinyu Wan^1*, Wenjie Li^1*, Jiaoyang Cai², Xiaomin Yang^1*, Liu Yang^1*, Jing Yang^1*, Tianyi Wang^1*, Yue Li^3*, Zichao Zhou^1*, Xiaoxi Lu^4*, Zhiwei Xie^3*, Jingbo Shao^5*, Meng Su^1*, Jing Zhang^1*, Juan Qian^1*, Kang An^1*, Chengjuan Luo^1*, Lixia Ding^6*, Lili Song^1*, Wenhua Shi^1*, Jun Lu^7*, Cheng Cheng^8*, Yanjing Tang^6*, Xuefeng Luo, MD^9*, Jingyu Li^9,10*, Jian Hua, MD^9,10*, Benshang Li, MD, PhD^6*, Hua Zhang, MD, PhD^9,10* and Ching-Hon Pui, MD¹¹

¹Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children’s Medical Center, Shanghai, China
²Key Laboratory of Pediatric Hematology & Oncology of the Ministry of Health of China, Department of Hematology & Oncology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
³Department of Pediatrics, Anhui Medical University Second Affiliated Hospital, Hefei, Anhui, China
⁴West China Second University Hospital, Sichuan University, Chengdu, China
⁵Department of Hematology/Oncology, Shanghai Children’s Hospital, Shanghai, China
⁶Department of Hematology/Oncology, Key Laboratory of Pediatric Hematology & Oncology Ministry of Health, Shanghai Children's Medical Center, Shanghai, China
⁷Department of Hematology/Oncology, Children's Hospital of Soochow University, Suzhou, China
⁸Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN
⁹SPH Biotherapeutics (Shanghai), Limited, Shanghai, China
¹⁰SPH Biotherapeutics (HK), Limited, Hong Kong, Hong Kong
¹¹Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN

Ruonan Li^1,2,3*, Lele Zhang^2,3*, Hong Pan^3,4*, Weiwang Li^2,3,5*, Jiaxiu Ma^1,3*, Linzhu Tian^1,2,3*, Yucan Shen^1,2,3*, Zhen Gao^1,2,3*, Jingyu Zhao, MSc^1,2,3*, Ke Huang^1,2,3*, Liyun Li^1,2,3*, Xiao Yu^1,2,3*, Zhexiang Kuang^2,3,6*, Meili Ge^3,7,8*, Liwei Fang^1,2,3*, Lijun Liu^1,3*, Weiping Yuan^3,9, Shuo Chen^1,3*, Lulu Lv, PhD^10*, Junhong Song^10*, Yi Feng^10*, Haiqing Xiong^1,3* and Jun Shi^1,2,3*

¹State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Red Blood Cell Diseases Center & Regenerative Medicine Clinic, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³Tianjin Institutes of Health Science, Tianjin, China
⁴Red Blood Cell Diseases Center & Regenerative Medicine Clinic, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, AL, China
⁵State Key Laboratory of Experimental Hematology,National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁶State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, AL, China
⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
⁸State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁹State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
¹⁰Juventas Cell Therapy Ltd, Tianjin, China

Yunju Ma, MD^1*, Qingya Cui^1*, Chunxiu Yang, MD^1*, Wei Cui^1*, Mengyun Li^1*, Zheng Li, MD^1*, Haiping Dai, MD^1*, Liqing Kang^2*, Lei Yu^2*, Zaixiang Tang^3*, Jianxin Fu^4*, Min Jiang^5*, Depei Wu, MD, PhD¹ and Xiaowen Tang^1*

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²Shanghai Unicar-Therapy Bio-Medicine Technology Co.,Ltd, Shanghai, China
³Department of Biostatistics, Soochow University, Suzhou, CHN
⁴Central Research Laboratory, the First Affiliated Hospital of Soochow University, Suzhou, China., Suzhou, China
⁵Department of Blood Transfusion, The First Affiliated Hospital of Soochow University, suzhou, China

Fabian Mueller, MD¹, Melanie Hagen, MD^2*, Andreas Wirsching, MD^2*, Soraya Kharboutli, MD^1*, Silvia Spoerl, MD^1*, Carlo Tur, MD^2*, Tobias Krickau, MD^3*, Laura Bucci, MD^2*, Christina Bergmann, MD^2*, Janina Auth, MD^2*, Panayiotis Garantziotis^2*, Sebastian Boeltz, MD^2*, Sascha Kretschmann, PhD^1*, Ingrid Vasova, MD^1*, Dimitrios Mougiakakos, MD⁴, Michael Aigner, PhD^1*, Ricardo Grieshaber-Bouyer, MD, PhD^2*, Markus Metzler, MD, PhD^3*, Simon Voelkl, PhD^1*, Georg Schett, MD^2* and Andreas Mackensen, MD^1*

¹Department of Internal Medicine 5 - Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
²Department of Internal Medicine 3 – Rheumatology, University Hospital of Erlangen, Erlangen, Germany
³Department of Pediatrics, University Hospital of Erlangen, Erlangen, Germany
⁴Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany